• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004年至2024年儿童代谢功能障碍相关脂肪性肝病的文献计量分析

A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024.

作者信息

Gong Xiaowei, Bai Siyu, Lei Enze, Lu Tao, Chen Yao, Cai Jianxin, Liu Jianzhong

机构信息

College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.

Department of Pediatrics, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China.

出版信息

Front Pediatr. 2025 Apr 28;13:1468788. doi: 10.3389/fped.2025.1468788. eCollection 2025.

DOI:10.3389/fped.2025.1468788
PMID:40356777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12066688/
Abstract

BACKGROUND

Metabolic dysfunction-associated steatotic liver disease (MASLD), once known as Non-alcoholic fatty liver disease, impacts between 3% and 10% of children and adolescents globally, as well as nearly one-third of obsessed boys and one-quarter of obsessed girls, and is the most frequent cause of pediatric liver disease associated with the obesity epidemic. With the growing attention and increasing volume of literature on pediatric MASLD, there is an urgent need for bibliometric analysis and visualization in the area of pediatric MASLD study in terms of dissecting study priorities.

METHODS

Literature was searched in the Web of Science Core Collection database, followed by categorization, bibliometric study as well as visual analysis conducted by applying software including Citespace, VOSviewer, and the R language. The study concentrated on analyzing information related to key authors, spatial and temporal distribution, core keywords, and important citations.

RESULTS

In total, 3,409 publications on pediatric MASLD were collected in the study, including 2,697 articles and 712 review articles. Between 2004 and 2024, the volume of publications had been constantly increasing per year. The country with the most numerous publications was the United States, which had extensive exchanges and collaborations with Italy, China, and England, followed by Italy. The had the greatest quantity of publications in this domain. The core literature was a clinical guideline. Insulin resistance, metabolic syndrome, steatohepatitis, hepatocellular carcinoma, cardiovascular risk, diabetes risk, diagnostic accuracy, lifestyle intervention, gut microbiome, probiotics, and metabolic dysfunction-associated steatotic liver disease were also hot topics and frontier trends in pediatric MASLD studies.

CONCLUSION

This research represents the inaugural application of bibliometric analysis to examine the developmental trajectory of pediatric MASLD studies over the past two decades, which reveals that the etiology, pathological changes of the liver, relationship with obesity, complications, comorbidities, diagnosis and treatments of pediatric MASLD are the key focuses and provides academic references for pediatric clinicians and scholars to grasp the hotspots, the cutting edge and the evolving trends in the area.

摘要

背景

代谢功能障碍相关脂肪性肝病(MASLD),曾被称为非酒精性脂肪性肝病,全球3%至10%的儿童和青少年受其影响,肥胖男孩中近三分之一、肥胖女孩中四分之一受影响,且是肥胖流行相关儿科肝病最常见的病因。随着对儿科MASLD的关注度不断提高以及该领域文献数量的增加,迫切需要对儿科MASLD研究领域进行文献计量分析和可视化,以剖析研究重点。

方法

在科学网核心合集数据库中检索文献,随后进行分类、文献计量研究以及运用Citespace、VOSviewer和R语言等软件进行可视化分析。该研究集中分析与关键作者、时空分布、核心关键词和重要引文相关的信息。

结果

该研究共收集到3409篇关于儿科MASLD的出版物,包括2697篇文章和712篇综述文章。2004年至2024年期间,出版物数量逐年持续增加。发表文章数量最多的国家是美国,其与意大利、中国和英国有广泛的交流与合作,其次是意大利。该领域发表文章数量最多的是 。核心文献是一份临床指南。胰岛素抵抗、代谢综合征、脂肪性肝炎、肝细胞癌、心血管风险、糖尿病风险、诊断准确性、生活方式干预、肠道微生物群、益生菌以及代谢功能障碍相关脂肪性肝病也是儿科MASLD研究的热点话题和前沿趋势。

结论

本研究首次应用文献计量分析来审视过去二十年儿科MASLD研究的发展轨迹,揭示了儿科MASLD的病因、肝脏病理变化、与肥胖的关系、并发症、合并症、诊断和治疗是关键重点,为儿科临床医生和学者把握该领域的热点、前沿和发展趋势提供了学术参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/440d8a570872/fped-13-1468788-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/987aa8817f39/fped-13-1468788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/1ddc78a47568/fped-13-1468788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/46bf90629a7d/fped-13-1468788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/66e56bcdc16f/fped-13-1468788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/f4cf62ba61f6/fped-13-1468788-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/a9b9c68d8470/fped-13-1468788-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/b71042554786/fped-13-1468788-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/440d8a570872/fped-13-1468788-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/987aa8817f39/fped-13-1468788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/1ddc78a47568/fped-13-1468788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/46bf90629a7d/fped-13-1468788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/66e56bcdc16f/fped-13-1468788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/f4cf62ba61f6/fped-13-1468788-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/a9b9c68d8470/fped-13-1468788-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/b71042554786/fped-13-1468788-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc3/12066688/440d8a570872/fped-13-1468788-g008.jpg

相似文献

1
A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024.2004年至2024年儿童代谢功能障碍相关脂肪性肝病的文献计量分析
Front Pediatr. 2025 Apr 28;13:1468788. doi: 10.3389/fped.2025.1468788. eCollection 2025.
2
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis.肠道微生物群与代谢功能障碍相关脂肪性肝炎的全球研究趋势:文献计量学和科学计量学分析的见解
Front Pharmacol. 2024 Jul 11;15:1390483. doi: 10.3389/fphar.2024.1390483. eCollection 2024.
3
Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN).印度儿科学会小儿胃肠病学、肝病学和营养学分会(ISPGHAN)关于代谢功能障碍相关脂肪性肝病的实践建议。
Indian Pediatr. 2024 Oct 15;61(10):919-934. Epub 2024 Sep 13.
4
Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis.代谢功能障碍相关脂肪性肝病(MASLD)和肥胖症的临床随机试验中的策略干预:系统评价、荟萃分析和文献计量学分析。
BMC Med. 2024 Nov 21;22(1):548. doi: 10.1186/s12916-024-03744-x.
5
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023).全球非酒精性脂肪性肝病治疗的趋势和热点:文献计量学和可视化分析(2010-2023)。
World J Gastroenterol. 2023 Oct 7;29(37):5339-5360. doi: 10.3748/wjg.v29.i37.5339.
6
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.肥胖儿童的代谢功能障碍相关脂肪性肝病(MASLD):肥胖医学协会(OMA)与专家联合观点(2025年)
Obes Pillars. 2025 Feb 1;14:100164. doi: 10.1016/j.obpill.2025.100164. eCollection 2025 Jun.
7
Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis.2012 年至 2021 年代谢功能障碍相关脂肪性肝病(MAFLD)研究的新兴趋势和热点:文献计量分析。
Front Endocrinol (Lausanne). 2023 Jan 24;14:1078149. doi: 10.3389/fendo.2023.1078149. eCollection 2023.
8
Visual analysis of research hotspots and trends in traditional Chinese medicine for depression in the 21st century: A bibliometric study based on citespace and VOSviewer.21世纪中医治疗抑郁症研究热点与趋势的可视化分析:一项基于CiteSpace和VOSviewer的文献计量学研究
Heliyon. 2024 Oct 24;11(1):e39785. doi: 10.1016/j.heliyon.2024.e39785. eCollection 2025 Jan 15.
9
Bibliometric analysis of the association between periodontal disease and cardiovascular disease.牙周病与心血管疾病关联的文献计量学分析
Heliyon. 2024 May 31;10(11):e32065. doi: 10.1016/j.heliyon.2024.e32065. eCollection 2024 Jun 15.
10
Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity.不当饮食通过腹部肥胖加剧代谢功能障碍相关脂肪性肝病。
Nutrients. 2024 Dec 5;16(23):4208. doi: 10.3390/nu16234208.

引用本文的文献

1
Adipokine and Hepatokines in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current and Developing Trends.代谢功能障碍相关脂肪性肝病(MASLD)中的脂肪因子和肝脏因子:现状与发展趋势
Biomedicines. 2025 Jul 30;13(8):1854. doi: 10.3390/biomedicines13081854.

本文引用的文献

1
Global research trends of pneumonia in children: a bibliometric analysis.儿童肺炎的全球研究趋势:一项文献计量分析
Front Pediatr. 2023 Nov 24;11:1306234. doi: 10.3389/fped.2023.1306234. eCollection 2023.
2
Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics.儿科非酒精性脂肪性肝病的饮食和营养干预。
Nutrients. 2023 Nov 18;15(22):4829. doi: 10.3390/nu15224829.
3
Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis.2002 年至 2022 年胆汁酸与非酒精性脂肪性肝病相关性的研究趋势和热点:文献计量分析。
Endocrinol Diabetes Metab. 2024 Jan;7(1):e460. doi: 10.1002/edm2.460. Epub 2023 Nov 8.
4
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023).全球非酒精性脂肪性肝病治疗的趋势和热点:文献计量学和可视化分析(2010-2023)。
World J Gastroenterol. 2023 Oct 7;29(37):5339-5360. doi: 10.3748/wjg.v29.i37.5339.
5
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
6
Bibliometric Analysis on GABA-A Receptors Research Based on CiteSpace and VOSviewer.基于CiteSpace和VOSviewer的γ-氨基丁酸A受体研究文献计量分析
J Pain Res. 2023 Jun 19;16:2101-2114. doi: 10.2147/JPR.S409380. eCollection 2023.
7
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).过氧化物酶体增殖物激活受体(PPARs)在非酒精性脂肪性肝病(NAFLD)发病机制中的作用。
Pharmacol Res. 2023 Jun;192:106786. doi: 10.1016/j.phrs.2023.106786. Epub 2023 May 3.
8
Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.中药和天然产物靶向调节肠道微生物群治疗肝脏疾病。
Front Immunol. 2023 Feb 2;14:1086078. doi: 10.3389/fimmu.2023.1086078. eCollection 2023.
9
Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review.益生菌与儿童和青少年非酒精性脂肪性肝病:系统评价。
Rev Esp Enferm Dig. 2023 Aug;115(8):418-427. doi: 10.17235/reed.2022.8796/2022.
10
Multiomics study of nonalcoholic fatty liver disease.多组学研究非酒精性脂肪性肝病。
Nat Genet. 2022 Nov;54(11):1652-1663. doi: 10.1038/s41588-022-01199-5. Epub 2022 Oct 24.